Martin Luther University Halle-Wittenberg

Arzneibuchanalytik, 2. Auflage


Martin-Luther-Universität Halle-Wittenberg
Naturwissenschaftliche Fakultät I - Biowissenschaften
Institut für Pharmazie

phone: +49 345 55 25175
phone: +49 345 55 25154
Sekretariat (Frau Nishnik)
fax: +49 345 55 27237

room 518.2
Kurt-Mothes-Str. 3
06120 Halle (Saale)

Further settings

Login for editors

Prof. Dr. rer. nat. habil. Peter Imming

Prof. Dr. rer.nat. habil. Peter Imming

Head of the Department of Pharmaceutical/Medicinal Chemistry and Clinical Pharmacy

Faculty of Natural Sciences I - Biosciences

Martin-Luther-Universitaet Halle-Wittenberg

Kurt-Mothes-Str. 3

06120 Halle (Saale)


Professional CV:

  • since 2004 Professor of Pharmaceutical Chemistry, Martin-Luther-Universitaet Halle-Wittenberg (Germany)
  • Visiting Professorships to
    Grigore T. Popa, University of Medicine and Pharmacy, Iași (Romania, 2019)
    Faculty of Chemistry, California Baptist University, Riverside (USA, 2018)
    Gdansk University of Technology (Poland, 2013)
    Ewha University (Republic of Korea, 2011)
    Busan National University, Busan (Republic of Korea, 2009)
    Addis Ababa University (Ethiopia, 2008)
    Yanbian University of Science and Technology (P. R. China, 2001)
    Teaching Topics: Drug design and development.
  • 2001-2004 Assistant Professor of Pharmaceutical Chemistry, Marburg
  • 1999-2001 Acting Chair of Pharmaceutical Chemistry, University of Muenter (Germany)
  • 1988-89 DFG scholarship-funded Postdoc with Prof. Dr. Jack E. Baldwin, Department of Organic Chemistry, University of Oxford, UK
  • Dr. rer.nat. (PhD) "summa cum laude" 1987, Philipps-Universitaet Marburg (Germany)

Committees and Review Boards (currently):

  • Member of evaluation and selection comittees of the German Academic Exchange Service (DAAD) (since 2018)
  • German Federal Ministry of Health, "Pharmadialogue", Member of the Committee for the Impact of Globalization on Healthcare (since 2017)
  • Member of the committee and chairman of the national group Saxony-Anhalt of the German pharmaceutical society (DPhG)
  • European & Developing Countries Clinical Trials Partnership (EDCTP) (since 2016)
  • Independent Expert to the European Commission, General Directorate Health (since 2007; FP7, Horizon 2020, Horizon Europe)

Research interests:

  • New drugs against tuberculosis and Mycobacterium abscessus infections: design, synthesis, physicochemical characterisation, assaying, pharmacokinetic investigation.
  • German Federal Ministry of Education and Research (BMBF) and German Academic Exchange Service (DAAD) funded TRISUSTAIN Project (investigation of antiinfective East African plants; project includes nine PhD students from or in Africa), see: Sustainable Development Goals (SDGs) 3, 8, 15
  • Stable radicals as EPR probes for diagnostic purposes.
  • Near Infrared Spectroscopy for Industrial Pharmaceutical Quality Control in cooperation with Bayer Bitterfeld GmbH (Germany and Switzerland).

Textbook (co)author:

  • "Chamomile - Industrial Profiles" (Hgg. R. Franke, H. Schilcher) CRC Press 2005
  • "Arzneibuchanalytik" (Scope and methods of pharmacopoeias), 2nd edition 2013.
  • "The Practice of Medicinal Chemistry" (eds. C.G. Wermuth et al.), 4th edition 2015, author of 1st chapter.